+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Photocure ASA (PHO) - Financial and Strategic SWOT Analysis Review

  • PDF Icon

    SWOT Analysis

  • 51 Pages
  • October 2021
  • GlobalData
  • Photocure ASA
  • ID: 1314757
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Photocure ASA (PHO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:


  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights


Photocure ASA (Photocure) is a specialty pharmaceutical company with focus on bladder cancer. It develops and markets pharmaceuticals for the diagnosis and treatment of bladder cancer and precancerous conditions based on its photodynamic technology. The company’s flagship product Hexvix is an intravesical solution used for the detection of bladder cancer. The company offers this product under the name Cysview in the US for the use in the cystoscopic detection of non-muscle invasive papillary cancer of the bladder. Photocure’s pipeline products include Cevira, a photodynamic drug-device combination product in the Phase II clinical studies for the treatment of HPV infection and precancerous lesions of the cervix. The company sells product directly through its own specialty and medical teams in the US and Nordic and through partnerships with Juno Pharmaceuticals and BioSyent Pharma.in Canada and Australia, New Zealand. Photocure is headquartered in Oslo, Norway.

Photocure ASA Key Recent Developments


Sep 15,2021: Photocure: Presentations of Blue Light flexible cystoscopy study results and bladder cancer surgical techniques featured at AUA 2021
Sep 01,2021: Photocure appoints Anders Neijber as Vice President, Global Medical Affairs and Clinical Development
Aug 11,2021: Photocure : Results for the second quarter of 2021
Aug 11,2021: Photocure Announces Results for the second quarter of 2021
Jul 13,2021: Photocure: New data presented at EAU 2021 highlight the effects of blue light cystoscopy on detection and recurrence of bladder cancer

Key benefits of buying this profile include:


You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Table of Contents

Section 1 - About the Company
  • Photocure ASA - Key Facts
  • Photocure ASA - Key Employees
  • Photocure ASA - Key Employee Biographies
  • Photocure ASA - Major Products and Services
  • Photocure ASA - History
  • Photocure ASA - Company Statement
  • Photocure ASA - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries

Section 2 - Company Analysis
  • Company Overview
  • Photocure ASA - Business Description
  • Business Segment: Commercial Franchise
  • Overview
  • Performance
  • Business Segment: Development Portfolio
  • Overview
  • Performance
  • Geographical Segment: Austria
  • Performance
  • Geographical Segment: France
  • Performance
  • Geographical Segment: Germany
  • Performance
  • Geographical Segment: Nordic countries
  • Performance
  • Geographical Segment: Other European Countries
  • Performance
  • Geographical Segment: Partner Countries Europe
  • Performance
  • Geographical Segment: Partner Countries Rest of World
  • Performance
  • Geographical Segment: The Netherlands
  • Performance
  • Geographical Segment: The UK
  • Performance
  • Geographical Segment: The US
  • Performance
  • Photocure ASA - Corporate Strategy
  • Photocure ASA - SWOT Analysis
  • SWOT Analysis - Overview
  • Photocure ASA - Strengths
  • Photocure ASA - Weaknesses
  • Photocure ASA - Opportunities
  • Photocure ASA - Threats
  • Photocure ASA - Key Competitors

Section 3 - Company Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Performance Chart
  • Financial Performance
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts

Section 4 - Company’s Lifesciences Financial Deals and Alliances
  • Photocure ASA, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
  • Photocure ASA, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
  • Photocure ASA, Recent Deals Summary

Section 5 - Company’s Recent Developments
  • Sep 15, 2021: Photocure: Presentations of Blue Light flexible cystoscopy study results and bladder cancer surgical techniques featured at AUA 2021
  • Sep 01, 2021: Photocure appoints Anders Neijber as Vice President, Global Medical Affairs and Clinical Development
  • Aug 11, 2021: Photocure : Results for the second quarter of 2021
  • Aug 11, 2021: Photocure Announces Results for the second quarter of 2021
  • Jul 13, 2021: Photocure: New data presented at EAU 2021 highlight the effects of blue light cystoscopy on detection and recurrence of bladder cancer
  • Jun 23, 2021: Photocure: New article published in Urologic Oncology: Macro and Microeconomics of Blue Light Cystoscopy with Cysview in non-muscle-invasive bladder cancer
  • May 19, 2021: Photocure : Results for the first quarter of 2021
  • Mar 03, 2021: Photocure ASA: Results for the fourth quarter of 2020
  • Feb 24, 2021: Photocure ASA: Invitation to presentation of fourth quarter and preliminary full year 2020 financial results
  • Nov 10, 2020: Photocure: Results for the third quarter of 2020

Section 6 - Appendix
  • Methodology
  • Ratio Definitions
  • About the publisher
  • Contact the publisher
  • Disclaimer

List of Tables
  • Photocure ASA, Key Facts
  • Photocure ASA, Key Employees
  • Photocure ASA, Key Employee Biographies
  • Photocure ASA, Major Products and Services
  • Photocure ASA, History
  • Photocure ASA, Subsidiaries
  • Photocure ASA, Key Competitors
  • Photocure ASA, Ratios based on current share price
  • Photocure ASA, Annual Ratios
  • Photocure ASA, Annual Ratios (Cont...1)
  • Photocure ASA, Annual Ratios (Cont...2)
  • Photocure ASA, Interim Ratios
  • Photocure ASA, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
  • Photocure ASA, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
  • Photocure ASA, Recent Deals Summary
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios

List of Figures
  • Photocure ASA, Performance Chart (2016 - 2020)
  • Photocure ASA, Ratio Charts
  • Photocure ASA, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
  • Photocure ASA, Pharmaceuticals & Healthcare, Deals by Type, 2015 to YTD 2021

Samples

Loading
LOADING...

Companies Mentioned

A selection of companies mentioned in this report includes:

  • ProBio Nutraceuticals AS
  • Nel ASA
  • Navamedic ASA
  • Medistim ASA
  • ArcticZymes Technologies ASA
  • Aqua Bio Technology ASA